Company

Siemens Healthineers Posts 5.7% Q1 2024 Sales Growth, Exceeds Pre-Pandemic Levels

CompanyDrug

Roche Posts Modest 2023 Growth Amid Shifts in Demand for COVID-Related Products

CompanyDeals

Teva Pharmaceuticals Initiates Spin-off of TAPI Unit, Targeting 2025 for Completion

CompanyDrug

Merck KGaA’s Tepmetko Launches in China, Expanding Access to MET Inhibitor for Lung Cancer Patients

CompanyDeals

Chia Tai Tianqing and Fudan University Shanghai Cancer Center Join Forces for Innovative Drug Development

Company

Takeda Secures Rights to Protagonist Therapeutics’ Rusfertide in Landmark Deal

CompanyDrug

Shanghai Junshi Biosciences’ Toripalimab Aims for Singapore Approval in Nasopharyngeal Carcinoma

Company

Novo Nordisk Delivers Strong 2023 Results with Record-Breaking Sales

Company

Sanofi Reports Full-Year Revenue Growth Driven by Dupixent and Vaccines, Eyes Biopharma Focus

CompanyDrug

Takeda Reports Flat 9-Month Revenue Growth Amid Pipeline Optimization Efforts

Company

Merck Q4 Sales Grow 6% YOY, Driven by Pharmaceutical Segment and HPV Vaccine Demand

CompanyDeals

Sanofi Secures Rights to Graviton’s ROCK2 Inhibitor Candidates in Strategic Biotechnology Investment